-

Agilent Included in Just Capital’s 2023 List of Most Just Companies

Ranking Underscores Agilent’s Strong Performance on Issues of Greatest Importance to Americans

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is ranked 35 among the top 100 Most JUST companies, the fifth year the company has been included in the annual list by Just Capital and CNBC. Agilent also earned the top ranking in its sector for industry-leading performance regarding treatment of employees, customers and the environment.

Just Capital and CNBC based the rankings on a review of the policies and practices of 1,000 of the largest U.S. public companies on issues that matter most to Americans, including wages and benefits, job creation, worker health and safety, ethical leadership, and environmental stewardship.

Agilent’s top ranking on worker issues reflects its commitment to being an employer of choice globally. In 2022, Agilent earned Great Place to Work® Certification in 20 countries and regions, including the United States, and was recently ranked among the best workplaces in health care by Fortune.

Just Capital also ranked Agilent number one in the industry for its treatment of customers. For the past two years, Agilent has ranked in the top five in customer satisfaction by the Wall Street Journal and the Drucker Institute’s annual list of the best-managed companies.

“Agilent employees work closely with our customers to bring great science to life and to carry out our mission to advance the quality of life,” said Neil Rees, Agilent’s head of Environmental, Social, and Governance (ESG) Programs. “Treating our employees well and creating products that help our customers improve human health and reduce environmental impact are essential to our ESG commitment.”

Agilent has reported on its corporate responsibility practices for over 20 years. The company is included in the JUST U.S. Large Cap Diversified (JULCD) Index and the Dow Jones Sustainability Indices (DJSI). Read more about Agilent’s commitment to net-zero emissions, diversity and inclusion, and other ESG initiatives.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

Social Media Profiles
More News From Agilent Technologies Inc.

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas. Agilent will highlight expanded biomarker testing capabilities, continued progress in digital pathology adoption, and the evolving role of the Dako Omnis family of instruments as a founda...

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company’s expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing so...

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

SANTA CLARA, Calif. & SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million. Biocare is a high-growth global pathology antibody leader, serving customers with a complementary portfolio of immunohistochemistry (IHC), in sit...
Back to Newsroom